In situ detection of PCR-amplified metalloproteinase cDNAs, their inhibitors and human papillomavirus transcripts in cervical carcinoma cell lines

International Journal of Cancer

Volumn 71, Issue 6, 1997, Pages 1056-1060

  Nuovo, Gerard J ^a  

^a MGN Medical Research Laboratory   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

COMPLEMENTARY DNA; MATRIGEL; MATRIX METALLOPROTEINASE; TISSUE INHIBITOR OF METALLOPROTEINASE; TRANSFORMING GROWTH FACTOR BETA1; VIRUS RNA;

ARTICLE; CANCER INVASION; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN CELL; IN SITU HYBRIDIZATION; PAPILLOMA VIRUS; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; UTERINE CERVIX CARCINOMA;

COLLAGEN; DNA, COMPLEMENTARY; DRUG COMBINATIONS; FEMALE; GLYCOPROTEINS; HELA CELLS; HUMANS; IN SITU HYBRIDIZATION; LAMININ; METALLOENDOPEPTIDASES; NEOPLASM INVASIVENESS; PAPILLOMAVIRIDAE; POLYMERASE CHAIN REACTION; PROTEINS; PROTEOGLYCANS; RNA, MESSENGER; TISSUE INHIBITOR OF METALLOPROTEINASE-2; TISSUE INHIBITOR OF METALLOPROTEINASES; UTERINE CERVICAL NEOPLASMS;

EID: 0030917658     PISSN: 00207136     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-0215(19970611)71:6<1056::AID-IJC23>3.0.CO;2-A     Document Type: Article

References (13)

1. DYSON, N., HOWLEY, P.M., MUNGER, K. and HAKLOW, E., The human papilloma virus-16 E7 oncoprotein is able to bind to the retinoblastoma gene product. Science, 243, 934-936 (1989).
2. KHOKHA, R., WATERHOUSE, P., YAGEL, S., LALA, P.K., OVERALL, C.M., NORTON, G. and DENHARDT, D.T., Amisense RNA-induced reduction in murine TIMP levels confers oncogenicity on Swiss 3T3 cells. Science. 243, 947-950 (1989).
3. LIOTTA, U.A., STEEG, P.S. and STETLER-STEVENSON, W.G., Cancer metastasis and angiogenesis: an imbalance of positive and negative regulation. Cell, 64, 327-336 (1991).
4. MCCANCE, D.J., KOPAN, R., FUCHS, E. and LAIMINS, L.A., Human papillomavirus type 16 alters human epithelial cell differentiation in vitro. Proc. nat. Acad. Sci. (Wash.), 85, 7169-7173 (1988).
5. MCDONNELL, S. and MATRISIAN, U.M., Stromelysin in tumor progression and metastasis. Cancer Metastasis Rev., 9, 305-319 (1990).
6. MCLACHLIN, C.M., TATE, J.E., SHEETS, E.E. and CRUM, C.P., Human papilloniavirus type 18 and intracpithelial lesions of the cervix. Amer. J. Pathol., 144, 141-147 (1994).
7. MIGNATTI, P., ROBBINS, E. and RIFKIN, D.B., Tumor invasion through the human amniotic membrane: requirement for a protease cascade. Cell, 47, 487-498 (1986).
8. Nuovo, G.J., Cytopathology of the lower female genital tract: em integrated approach. Williams & Wilkins. Baltimore (1993).
9. Nuovo, G.J., MACCONNELL, P. and FRENCH, D.L., Correlation of the in situ detection of PCR-amplified metalloprotease cDNAs and their inhibitors with prognosis in cervical carcinoma. Cancer Res., 55, 267-275 (1995).
10. NUOVO, G.J., PCR in situ hybridization: protocols and applications, (3rd ed.). Lippincott-Raven. Philadelphia (1996).
11. PECORARO, G., LEE, M., MORGAN, D. and DEFENDI, V., Evolution of in vitro transformation and tumorigencsis of HPV 16 and HPV 18 immortalized primary cervical epithelial cells. Amer. J. Pathol., 138, 1-8 (1991).
12. 131I-labeled monoclonal antibodies. Anticancer Res., 10, 379-384 (1992).
13. VACCARIELLO, M., JAVAHERIAN, A. and GARLICK, J., A tissue model to study clonal expansion in intraepithelial neoplasia. Proc. Ann. Meet. Amer. Assoc. Cancer Res., 37, A774 (1996).